Informed consent: patient information forms in chemotherapy trials

Area of Science:

• Oncology
• Medical Ethics
• Health Communication

Background:

• Informed consent is crucial for clinical trials, yet current lengthy consent forms often confuse patients.
• Federal regulations necessitate detailed consent documentation, but this may paradoxically hinder patient understanding.

Purpose of the Study:

• To assess patient preference for different lengths of clinical trial consent forms.
• To determine if patient characteristics or autonomy indicators correlate with preferences for information detail.
• To evaluate the impact of consent form length on patient comprehension of study design.

Main Methods:

• Seventy-five women undergoing chemotherapy for advanced breast cancer participated.
• Patients' preferences for long, medium, or short consent forms were assessed.
• Comprehension of basic study design was tested after reviewing forms of varying lengths.

Main Results:

• A majority of patients preferred more detailed information.
• Despite this preference, most patients given detailed forms answered basic study questions incorrectly.
• Form length preference did not correlate with patient autonomy, physician dependency, age, marital status, or education level.
• Longer forms did not increase patient stress compared to shorter forms.

Conclusions:

• Patient preference for detailed consent forms does not guarantee improved understanding.
• Current consent form design may be inadequate for ensuring true informed consent.
• Further research and more careful design and evaluation of patient information forms are essential.